Firesorb™ Granted Green Channel Status for CFDA Approval
Shanghai, China - Firesorb™ Bioresorbable Rapamycin Target Eluting Coronary Scaffold System ("Firesorb™"), the second-generation fully bioresorbable scaffold in-house developed by Shanghai MicroPort Medical (Group) Co ("MicroPort®"), was recently granted by China Food and Drug Administration ("CFDA") the Green Channel status, a special fast-track procedure for innovative medical devices to gain CFDA approval. This will significantly shorten the approval time, and MicroPort® is expected to provide a better solution of bioresorbable scaffold to domestic patients with coronary heart diseases in the near future.
As the second-generation fully bioresorbable scaffold, Firesorb™ features thinner strut which could lower the crossing profile, shorten the bio-degradation time, so as to reduce the risk of postoperative thrombosis. In Firesorb™'s target-eluting design, the drug only retains on one surface that contacts blood vessels, with 60% less drug loadings compared to similar products. Such design reduces the dose of drug, enhances the efficiency of the treatment, and prevents a large amount of drug residual from remaining in the body for a long time, while achieving the same clinical efficacy as other bioresorbable scaffolds.
MicroPort® has completed the patient enrollment for FUTURE-I, the perspective, single group observation, First-in-Man ("FIM") clinical trial of evaluating the safety and efficacy of Firesorb™ in the treatment of coronary heart diseases, with related studies running smoothly.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.